These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 23795224)

  • 1. Geriatric assessment is associated with completion of chemotherapy, toxicity, and survival in older adults with cancer.
    Wildes TM; Ruwe AP; Fournier C; Gao F; Carson KR; Piccirillo JF; Tan B; Colditz GA
    J Geriatr Oncol; 2013 Jul; 4(3):227-34. PubMed ID: 23795224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Palliative chemotherapy in elderly patients with common metastatic malignancies: A Hellenic Cooperative Oncology Group registry analysis of management, outcome and clinical benefit predictors.
    Pentheroudakis G; Fountzilas G; Kalofonos HP; Golfinopoulos V; Aravantinos G; Bafaloukos D; Papakostas P; Pectasides D; Christodoulou C; Syrigos K; Economopoulos T; Pavlidis N;
    Crit Rev Oncol Hematol; 2008 Jun; 66(3):237-47. PubMed ID: 18243010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of multidimensional comorbidities with survival, toxicity, and unplanned hospitalizations in older adults with metastatic colorectal cancer treated with chemotherapy.
    Kim KH; Lee JJ; Kim J; Zhou JM; Gomes F; Sehovic M; Extermann M
    J Geriatr Oncol; 2019 Sep; 10(5):733-741. PubMed ID: 30765268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer Aging Research Group (CARG) score in older adults undergoing curative intent chemotherapy: a prospective cohort study.
    Ostwal V; Ramaswamy A; Bhargava P; Hatkhambkar T; Swami R; Rastogi S; Mandavkar S; Ghosh J; Bajpai J; Gulia S; Srinivas S; Rath S; Gupta S
    BMJ Open; 2021 Jun; 11(6):e047376. PubMed ID: 34187825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors Predicting Adherence to a Tailored-Dose Adjuvant Treatment on the Basis of Geriatric Assessment in Elderly People With Colorectal Cancer: A Prospective Study.
    Antonio M; Carmona-Bayonas A; Saldaña J; Navarro V; Tebé C; Salazar R; Borràs JM
    Clin Colorectal Cancer; 2018 Mar; 17(1):e59-e68. PubMed ID: 29054805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrating geriatric assessment in the first line chemotherapy treatment in older patients with metastatic colorectal cancer: Results of a prospective observational cohort study (AVAPLUS).
    Decoster L; Kenis C; Naessens B; Houbier G; De Man M; Lambrecht G; Monsaert E; Moons V; Vergauwe P; Prenen H; Van Cutsem E; Wildiers H
    J Geriatr Oncol; 2018 Mar; 9(2):93-101. PubMed ID: 29133190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotoxicity recurrence in older patients: Risk factors and effectiveness of preventive strategies-a prospective study.
    Extermann M; Reich RR; Sehovic M
    Cancer; 2015 Sep; 121(17):2984-92. PubMed ID: 26033177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Geriatric factors predict chemotherapy feasibility: ancillary results of FFCD 2001-02 phase III study in first-line chemotherapy for metastatic colorectal cancer in elderly patients.
    Aparicio T; Jouve JL; Teillet L; Gargot D; Subtil F; Le Brun-Ly V; Cretin J; Locher C; Bouché O; Breysacher G; Charneau J; Seitz JF; Gasmi M; Stefani L; Ramdani M; Lecomte T; Mitry E
    J Clin Oncol; 2013 Apr; 31(11):1464-70. PubMed ID: 23460711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study.
    Hurria A; Togawa K; Mohile SG; Owusu C; Klepin HD; Gross CP; Lichtman SM; Gajra A; Bhatia S; Katheria V; Klapper S; Hansen K; Ramani R; Lachs M; Wong FL; Tew WP
    J Clin Oncol; 2011 Sep; 29(25):3457-65. PubMed ID: 21810685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced-dose combination chemotherapy (S-1 plus oxaliplatin) versus full-dose monotherapy (S-1) in older vulnerable patients with metastatic colorectal cancer (NORDIC9): a randomised, open-label phase 2 trial.
    Winther SB; Liposits G; Skuladottir H; Hofsli E; Shah CH; Poulsen LØ; Ryg J; Osterlund P; Berglund Å; Qvortrup C; Glimelius B; Sorbye H; Pfeiffer P
    Lancet Gastroenterol Hepatol; 2019 May; 4(5):376-388. PubMed ID: 30852136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of three-month mortality and severe chemotherapy-related adverse events in patients aged 70 years and older with metastatic non-small-cell lung cancer: A secondary analysis of ESOGIA-GFPC-GECP 08-02 study.
    Gendarme S; Zebachi S; Corre R; Greillier L; Justeau G; Bylicki O; Decroisette C; Auliac JB; Guisier F; Geier M; Ricordel C; Frelaut M; Paillaud E; Chouaïd C; Canouï-Poitrine F
    J Geriatr Oncol; 2024 Jul; 15(6):101506. PubMed ID: 37211514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of geriatric intervention in frail elderly patients receiving chemotherapy for colorectal cancer: a randomized trial (GERICO).
    Lund CM; Vistisen KK; Dehlendorff C; Rønholt F; Johansen JS; Nielsen DL
    BMC Cancer; 2017 Jun; 17(1):448. PubMed ID: 28659138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting the Risks of Aggressive-Intent Chemotherapy Toxicity in Older Patients With Lymphoma: A Prospective Observational Pilot Study.
    Dhir V; Maganti M; Rozenberg D; Kukreti V; Kuruvilla J; Crump M; Prica A
    Clin Lymphoma Myeloma Leuk; 2022 Aug; 22(8):e792-e803. PubMed ID: 35650009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective, longitudinal study of the functional status and quality of life of older patients with breast cancer receiving adjuvant chemotherapy.
    Hurria A; Hurria A; Zuckerman E; Panageas KS; Fornier M; D'Andrea G; Dang C; Moasser M; Robson M; Seidman A; Currie V; VanPoznak C; Theodoulou M; Lachs MS; Hudis C
    J Am Geriatr Soc; 2006 Jul; 54(7):1119-24. PubMed ID: 16866685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequential Geriatric Assessment in Older Patients with Colorectal Cancer during Chemotherapy: Subgroup Analysis of a Prospective, Multicenter Study EpiReal 75.
    Li M; Schulte N; Elting F; Winkler EC; Hetjens S; Berger AK; Zschäbitz S; Hofmann J; Hofmann J; Hilbertz L; Kuhn M; Khakzar C; Jesenofsky R; Betge J; Zhan T; Belle S; Ebert MP; Härtel N
    Oncol Res Treat; 2022; 45(11):670-680. PubMed ID: 35675788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paclitaxel and carboplatin in combination in the treatment of advanced non-small-cell lung cancer: a phase II toxicity, response, and survival analysis.
    Langer CJ; Leighton JC; Comis RL; O'Dwyer PJ; McAleer CA; Bonjo CA; Engstrom PF; Litwin S; Ozols RF
    J Clin Oncol; 1995 Aug; 13(8):1860-70. PubMed ID: 7543559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frailty assessment predicts toxicity during first cycle chemotherapy for advanced lung cancer regardless of chronologic age.
    Ruiz J; Miller AA; Tooze JA; Crane S; Petty WJ; Gajra A; Klepin HD
    J Geriatr Oncol; 2019 Jan; 10(1):48-54. PubMed ID: 30005982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Geriatric factors analyses from FFCD 2001-02 phase III study of first-line chemotherapy for elderly metastatic colorectal cancer patients.
    Aparicio T; Gargot D; Teillet L; Maillard E; Genet D; Cretin J; Locher C; Bouché O; Breysacher G; Seitz JF; Gasmi M; Stefani L; Ramdani M; Lecomte T; Auby D; Faroux R; Bachet JB; Lepère C; Khemissa F; Sobhani I; Boulat O; Mitry E; Jouve JL;
    Eur J Cancer; 2017 Mar; 74():98-108. PubMed ID: 27825697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multicenter Phase II Study of Sequential Brentuximab Vedotin and Doxorubicin, Vinblastine, and Dacarbazine Chemotherapy for Older Patients With Untreated Classical Hodgkin Lymphoma.
    Evens AM; Advani RH; Helenowski IB; Fanale M; Smith SM; Jovanovic BD; Bociek GR; Klein AK; Winter JN; Gordon LI; Hamlin PA
    J Clin Oncol; 2018 Oct; 36(30):3015-3022. PubMed ID: 30179569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Body Mass Index (BMI) on Chemotherapy-associated Toxicity in Ovarian Cancer Patients. A Pooled Analysis of the North-Eastern German Society of Gynecological Oncology (NOGGO) Databank on 1,213 Patients.
    Grabowski JP; Richter R; Rittmeister H; Chekerov R; Woopen H; Sehouli J
    Anticancer Res; 2018 Oct; 38(10):5853-5858. PubMed ID: 30275210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.